ɬ﷬

Journal News

Influenza gets help from gum disease bacteria

Emily Ulrich
May 15, 2025

Scientists know that bacteria in the respiratory tract, such as specific Staphylococcus aureus strains, can boost influenza infectivity by supplying a protease that cleaves the viral spike protein hemagglutinin, a step that facilitates viral host entry. The bacterium Porphyromonas gingivalis causes periodontal disease and has been associated with severe cases of influenza, but scientists have not determined whether this connection involves hemagglutinin cleavage by a specific enzyme. In a recent from the Journal of Biological Chemistry, Noriaki Kamio and a team at Nihon University in Japan investigated the link between P. gingivalis and influenza infectivity.

The authors used immunofluorescence microscopy and a canine kidney cell line to determine that an element in the supernatant of P. gingivalis culture enhanced cell-to-cell spread of influenza, similar to cells treated with trypsin protease. The researchers hypothesized that the supernatant contains a protease that can cleave viral hemagglutinin. They suspected that the gingipain cysteine proteases Rgp and Kgp produced by P. gingivalis could perform this function.

They tested the involvement of each protease by adding individual inhibitors of Rgp and Kgp to the supernatant and found that only the Rgp inhibitor blocked hemagglutinin cleavage. In addition, the authors showed that supernatant from a P. gingivalis strain lacking Rgp could not cleave hemagglutinin. They also performed a plaque assay to measure viral titers and found that the viral concentration was lower when cells were incubated with the bacterial strain missing Rgp. Therefore, they concluded that Rgp likely cleaves hemagglutinin and enhances viral replication.

The authors suggested that future studies using human respiratory cells and animal models will help unravel details of how P. gingivalis strengthens influenza infectivity. These results may help scientists pinpoint proteins in other bacteria that may promote respiratory viral spread.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Emily Ulrich

Emily Ulrich is the ASBMB’s science editor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.